Impact of fluoroquinolone treatment on delay of tuberculosis diagnosis: A systematic review and meta-analysis

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Volumn 6, Issue , 2017, Pages 1-7

  Hogan, Catherine A ^a   Puri, Lekha ^a   Gore, Genevieve ^b   Pai, Madhukar ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MANIPAL UNIVERSITY   (India)

Author keywords

Diagnostic delay; Fluoroquinolones; Tuberculosis

Indexed keywords

EID: 85006375112     PISSN: None     EISSN: 24055794     Source Type: Journal    
DOI: 10.1016/j.jctube.2016.12.001     Document Type: Article

References (20)

1. [1] Center for Disease Dynamics, Economics and Policy. State of the world's antibiotics, 2015. 2015, CDDEP, Washington, D.C.
2. [2] Tuberculosis Coalition for Technical Assistance. International standards for tuberculosis care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance, 2006.
3. [3] Das, J., Kwan, A., Daniels, B., Satyanarayana, S., Subbaraman, R., Bergkvist, S., et al. Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. Lancet Infect Dis 15:November(11) (2015), 1305–1313, 10.1016/S1473-3099(15)00077-8.
4. [4] Satyanarayana, S., Kwan, A., Daniels, B., Subbaraman, R., McDowell, A., Bergkvist, S., et al. Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study. Lancet Infect Dis, 2016, 10.1016/S1473-3099(16)30215-8 Aug 24.
5. [5] Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., Dean, N.C., et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44:Suppl 2 (2007), S27–S72 Mar 1.
6. [6] Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., et al. Joint Taskforce of the European respiratory society and European Society for clinical microbiology and infectious diseases.Guidelines for the management of adult lower respiratory tract infections–full version. Clin Microbiol Infect 17:November (Suppl 6) (2011), E1–59.
7. [7] Chen, T.C., Lu, P.L., Lin, C.Y., Lin, W.R., Chen, Y.H., Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis 15:March(3) (2011), e211–e216, 10.1016/j.ijid.2010.11.008.
8. [8] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., The PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med, 6(7), 2009, e1000097, 10.1371/journal.pmed.1000097.
9. [9] Qin, Z.Z. Delays in diagnosis and treatment of pulmonary tuberculosis, and patient care-seeking pathways in China: a systematic review and meta-analysis. Master's thesis. 2015.
10. [10] Cremades, R., Rodríguez, J.C., García-Pachón, E., Galiana, A., Ruiz-García, M., López, P., et al. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. J Antimicrob Chemother 66:October(10) (2011), 2281–2283, 10.1093/jac/dkr281.
11. [11] Rush, B., Wormsbecker, A., Stenstrom, R., Kassen, B., Moxifloxacin use and its association on the diagnosis of pulmonary tuberculosis in an inner city emergency department. J Emerg Med 50:March(3) (2016), 371–375, 10.1016/j.jemermed.
12. [12] Wang, J.Y., Lee, C.H., Yu, M.C., Lee, M.C., Lee, L.N., Wang, J.T., Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study. Eur Respir J 46:August(2) (2015), 567–570, 10.1183/09031936.00019915.
13. [13] Kim, S.Y., Yim, J.J., Park, J.S., Park, S.S., Heo, E.Y., Lee, C.H., et al. Clinical effects of gemifloxacin on the delay of tuberculosis treatment. J Korean Med Sci 28:March(3) (2013), 378–382, 10.3346/jkms.2013.28.3.378.
14. [14] Wang, M., Fitzgerald, J.M., Richardson, K., Marra, C.A., Cook, V.J., Hajek, J., et al. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?. Int J Tuberc Lung Dis 15:August(8) (2011), 1062–1068, 10.5588/ijtld.10.0734.
15. [15] Jeon, C.Y., Calver, A.D., Victor, T.C., Warren, R.M., Shin, S.S., Murray, M.B., Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community. Int J Tuberc Lung Dis 15:January(1) (2011), 77–83.
16. [16] Wang, J.Y., Hsueh, P.R., Jan, I.S., Lee, L.N., Liaw, Y.S., Yang, P.C., et al. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax. 61:October(10) (2006), 903–908, 10.1136/thx.2005.056887.
17. [17] Sierros, V., Khan, R., Joo Lee, H., Sabayev, V., The effect of fluoroquinolones on the acid-fast bacillus smear and culture of patients with pulmonary tuberculosis. Clin Pulm Med 13:May(3) (2006), 164–168, 10.1097/01.cpm.0000218459.07407.1d.
18. [18] Golub, J.E., Bur, S., Cronin, W.A., Gange, S., Sterling, T.R., Oden, B., et al. Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis. Int J Tuberc Lung Dis 9:April(4) (2005), 392–397.
19. [19] Yoon, Y.S., Lee, H.J., Yoon, H.I., Yoo, C.G., Kim, Y.W., Han, S.K., et al. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia. Int J Tuberc Lung Dis 9:November(11) (2005), 1215–1219.
20. [20] Dooley, K.E., Golub, J., Goes, F.S., Merz, W.G., Sterling, T.R., Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis 34:12 (2002), 1607–1612, 10.1086/340618 Jun 15.